Severe COVID-19 Pneumonia treated with Tocilizumab in a Pakistani population: Variables impacting Outcomes

Background: The association of severity of COVID-19 with raised Interleukin-6 (IL-6) levels led to Tocilizumab (TCZ) approval for treatment based on its IL-6 inhibiting mechanism of action. Treatment outcomes reported have been variable, with little data from Pakistan. Objective: To identify demog...

Full description

Bibliographic Details

Published in:	Journal of Liaquat National Hospital
Main Authors:	Sumaira Farman, Madeeha Habib Kamil Raja, Muhammad Kamil Hussain Raja, Syed Muhammad Daniyal Amjad, Muhammad Ahmed Saeed, Nadia Majeed, Nighat Mir Ahmad
Format:	Article
Language:	English
Published:	Liaquat National Hospital and Medical College 2024-04-01
Subjects:	coronavirus-19 covid-19 covid-19 pneumonia tocilizumab microthrombi il-6 anticoagulation
Online Access:	https://journals.lnh.edu.pk/jlnh/pdf/b8804579-7acc-476e-9b2c-8eff9f4e5c8f.pdf